Creativity related to dopaminergic treatment: A multicenter study

Area of Science:

• Neuroscience
• Neurology
• Psychiatry

Background:

• Dopaminergic treatments, particularly dopamine agonists (DAs), are associated with impulse control disorders (ICDs) like pathological gambling and hypersexuality in patients with Parkinson's disease (PD).
• Conversely, enhanced creativity, often manifesting as artistic engagement, is a less recognized but potentially positive side effect of DA therapy in PD patients.
• ICD is well-documented, while enhanced creativity remains underreported due to its typically non-disruptive and beneficial nature.

Purpose of the Study:

• To investigate the phenomenon of enhanced creativity in patients undergoing dopaminergic treatment.
• To explore the characteristics and prevalence of artistic engagement as a side effect of dopamine agonist therapy in Parkinson's disease.

Main Methods:

• A study was conducted on 21 patients (20 with PD, 1 with restless-legs syndrome) who exhibited enhanced creativity.
• Patient treatment history, specifically dopaminergic therapy (primarily dopamine agonists like pramipexole, ropinirole, and rotigotine), was reviewed.
• The nature and types of artistic activities pursued by the patients were documented.

Main Results:

• All but one of the 21 patients studied were treated with dopamine agonists.
• Enhanced creativity manifested primarily as engagement in artistic activities, with painting being the most common preference.
• Many patients participated in multiple artistic activities concurrently.

Conclusions:

• Dopaminergic treatment, especially with dopamine agonists, can lead to enhanced creativity and artistic expression in patients with Parkinson's disease.
• This positive phenomenon is likely underreported and may be more frequent than currently recognized.
• Further research is warranted to understand the mechanisms and implications of this creativity enhancement in a therapeutic context.